View Post

The Paired Perils of Breast Cancer and Diabetes

In In The News by Barbara Jacoby

From: ucsdnews.ucsd.edu Study describes mechanism by which breast cancer suppresses insulin production, impairing blood sugar regulation and causing diabetes, which, in turn, promotes tumor growth Breast cancer and type 2 diabetes would seem to be distinctly different diseases, with commonality only in their commonality. Breast cancer is the second most diagnosed malignancy after some types of skin cancer; approximately 1 …

View Post

Trial Touts 81% Response Rate in Locally Advance Breast Cancer

In In The News by Barbara Jacoby

By: Mark Terry From: biospace.com Researchers at Houston Methodist Hospital have published a study describing how chemotherapy and a drug commonly used to treat cardiac failure is able to regress tumor growth of patients with triple negative breast cancer and prevent it from further spreading. Researchers led by Jenny Chang, director of the Cancer Center at Houston Methodist and Emily …

View Post

Investigators Combine Zanidatamab With Evorpacept to Potentially Improve Outcomes in HER2-Expressing Breast Cancer

In Clinical Studies News by Barbara Jacoby

By: Nichole Tucker From: targetedonc.com Zanidatamab in combination with evorpacept has been dosed for the first time in a patient with HER2-low breast cancer. The first patient has been dosed with the combination of zanidatamab and evorpacept (ALX148) in a phase 1b/2 study evaluating the safety and efficacy of the combination in HER2-low breast cancer, and additional non-breast HER2-expressing solid …

View Post

Study investigates the effects of calycosin on breast cancer cell progression

In Clinical Studies News by Barbara Jacoby

From: news-medical.net Aging-US published “Calycosin inhibits breast cancer cell migration and invasion by suppressing EMT via BATF/TGF-β1” which reported that in this study, the authors investigated the effects of calycosin on breast cancer cell progression and their underlying mechanisms. Calycosin dose- and time-dependently inhibited proliferation, migration, and invasion by T47D and MCF-7 breast cancer cells by downregulating basic leucine zipper …

View Post

A pill for breast cancer? There’s one for early-stage patients with aggressive cases — and it works

In In The News by Barbara Jacoby

By: Peter Loftus, Wall Street Journal From: geneticliteracyproject.org A drug sold by AstraZeneca and Merck & Co. reduced the recurrence of breast cancer in women with an early but aggressive form of the disease, a long-running international study found. The finding, which on [June 3] was published online by the New England Journal of Medicine and released at a major …

View Post

How Image Visualization Complimented My Cancer Treatment

In In The News by Barbara Jacoby

From: curetoday.com curetoday.com How the act of image visualization and mediation gave this cancer survivor a helpful complement to her cancer treatment. The oncologist diagnosed me with stage 3 breast cancer. I felt flung into icy waters, as cancer hyphenated my life into ‘Before’ and ‘After’ eras. ‘Before’ saw a confident, energetic 58-year-old professor traveling widely. ‘After’ saw a sick, …

View Post

Disrupted immune cell navigation in lymph nodes of breast cancer patients

In In The News by Barbara Jacoby

From: miragenews.com In breast cancer, tumours of different types have divergent effects on the functioning of the lymph nodes. In patients with invasive breast cancer, the blood vessels and supporting tissue of the lymph nodes change, but this does not occur in patients with a non-invasive form of breast cancer (ductal carcinoma in situ). This is shown in a new …

View Post

Older Women Without Breast Cancer May Inappropriately View Certain Treatment Options as Negatively Impacting Prognosis

In In The News by Barbara Jacoby

By: Colleen Moretti From: curetoday.com Older women without hormone receptor (HR) positive breast cancer are still experiencing overtreatment despite national recommendations to omit, due to lack of reframing prognosis and education on treatment risks, according to a study published in Jama. “Positive reframing of recommendations to avoid (sentinel lymph node biopsy) and radiotherapy may be a strategy to reduce overtreatment …

View Post

AI-powered microscope could check cancer margins in minutes

In In The News by Barbara Jacoby

Source: Rice University From: rice.edu When surgeons remove cancer, one of the first questions is, “Did they get it all?” Researchers from Rice University and the University of Texas MD Anderson Cancer Center have created a new microscope that can quickly and inexpensively image large tissue sections, potentially during surgery, to find the answer. The microscope can rapidly image relatively …

View Post

Study Finds Lobular Breast Cancer Associated with Distinct Characteristics

In Clinical Studies News by Barbara Jacoby

By: Hannah Slater From: cancernetwork.com The collective study findings suggested that for risk assessment, the recurrence score needs to be complemented by clinicopathologic parameters for therapy decision making. A study published in Cancer confirmed that lobular breast cancer is associated with distinct characteristics, including lower histologic grade, lower Ki67, and low or intermediate recurrence score results but higher tumor classification. …